Does REPAGLINIDE Cause Hyperglycaemia? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Hyperglycaemia have been filed in association with REPAGLINIDE (Repaglinide). This represents 2.6% of all adverse event reports for REPAGLINIDE.
66
Reports of Hyperglycaemia with REPAGLINIDE
2.6%
of all REPAGLINIDE reports
0
Deaths
28
Hospitalizations
How Dangerous Is Hyperglycaemia From REPAGLINIDE?
Of the 66 reports, 28 (42.4%) required hospitalization, and 13 (19.7%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does REPAGLINIDE Cause?
Hypoglycaemia (665)
Acute kidney injury (281)
Lactic acidosis (163)
Hypoglycaemic coma (125)
Sopor (91)
Confusional state (89)
Drug interaction (89)
Blood glucose increased (88)
Diarrhoea (87)
Dyspnoea (87)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which REPAGLINIDE Alternatives Have Lower Hyperglycaemia Risk?
REPAGLINIDE vs REPOTRECTINIB
REPAGLINIDE vs REQUIP
REPAGLINIDE vs RESLIZUMAB
REPAGLINIDE vs RESMETIROM
REPAGLINIDE vs RESTASIS